Home > Boards > US Listed > Biotechs > Nabriva Therapeutics AG (NBRV)

Great news!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DorseyE Member Profile
 
Followed By 8
Posts 2,055
Boards Moderated 0
Alias Born 08/09/03
160x600 placeholder
Quarterly Report (10-q) Edgar (US Regulatory) - 8/6/2020 4:14:08 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/6/2020 4:02:31 PM
Nabriva Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Updates GlobeNewswire Inc. - 8/6/2020 4:01:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2020 4:59:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2020 4:10:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2020 4:09:40 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2020 4:09:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/4/2020 4:08:39 PM
Nabriva Therapeutics to Report Second Quarter 2020 Financial Results on August 6, 2020 GlobeNewswire Inc. - 8/3/2020 7:00:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/31/2020 4:56:33 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/31/2020 4:56:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/31/2020 4:55:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/31/2020 4:55:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/31/2020 4:54:37 PM
Nabriva Therapeutics to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference GlobeNewswire Inc. - 7/30/2020 4:01:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2020 6:12:04 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 7/30/2020 6:10:17 AM
NABRIVA Receives European Approval for XENLETA® (lefamulin) for Treatment of Community-Acquired Pneumonia (CAP) GlobeNewswire Inc. - 7/28/2020 10:02:52 AM
Lefamulin Demonstrates Anti-Inflammatory Activity in Pre-Clinical Study GlobeNewswire Inc. - 7/23/2020 7:00:10 AM
U.S. Small Cap Stocks Could Outperform The Market During The Recovery And Here Are Four Stocks You Need To Know About GlobeNewswire Inc. - 7/22/2020 7:00:10 AM
XENLETA® (lefamulin) Receives Health Canada Approval for Treatment of Community Acquired Pneumonia GlobeNewswire Inc. - 7/16/2020 4:04:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/15/2020 4:52:28 PM
Nabriva Therapeutics Enters into Exclusive Agreement to Promote and Distribute SIVEXTRO® (tedizolid phosphate) in the U.S. GlobeNewswire Inc. - 7/15/2020 4:01:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2020 5:55:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/2/2020 4:37:39 PM
DorseyE   Sunday, 03/15/20 09:43:14 PM
Re: None
Post # of 395 
Great news!

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist